GSC
ZYME icon

Grey Street Capital’s Zymeworks ZYME Stock Holding History

Grey Street Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$260K Buy
+24,689
New +$274K 0.04% 420

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Grey Street Capital's ZYME Position: Q1 2024 in Review

Grey Street Capital opened a new position in Zymeworks (ZYME) in Q1 2024: 24,689 shares worth $260K. The stake represents 0.04% of the portfolio and ranks #420 among its holdings.

171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

  • Grey Street Capital held 24,689 shares of Zymeworks worth $260K as of Q1 2024.
  • Zymeworks was a new Grey Street Capital position in Q1 2024.
  • Zymeworks made up 0.04% of Grey Street Capital's portfolio in Q1 2024, its #420 holding.
  • 171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.